ADVB
Advanced Biomed Inc.
Price Chart
Latest Quote
$3.00
+0.27 (+9.89%)
Current Price
| Previous Close | $2.73 |
| Open | $2.76 |
| Day High | $3.00 |
| Day Low | $2.72 |
| Volume | 19,288 |
Stock Information
| Shares Outstanding | 1.65M |
| Total Debt | $1.08M |
| Cash Equivalents | $386K |
| Revenue | $128K |
| Net Income | $-6.26M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $4.96M |
| EPS (TTM) | $-5.00 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $5.20M |
| Sales | $128K |
| Income | $-6.26M |
| Book/sh | $7.43 |
| Cash/sh | $0.23 |
| Employees | 12 |
Financial Ratios
| Quick Ratio | 9.33 |
| Current Ratio | 9.33 |
| Debt/Eq | 8.78 |
Returns & Margins
| ROA | -21.28% |
| ROE | -79.49% |
| Gross Margin | 100.00% |
| Operating Margin | -3856.40% |
| Profit Margin | 5231.30% |
Ownership
| Insider Ownership | 61.41% |
| Institutional Ownership | 1.40% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 38.83 |
| P/B | 0.40 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $4.94 |
| SMA50 | $6.86 |
| SMA200 | $5.99 |
| RSI | 10.95 |
| ATR | 0.5833 |
| Shares Float | 677K |
| Short Float | 2.17% |
| Short Ratio | 0.28 |
| Rel Volume | 0.52 |
Performance History
| Week | -21.05% |
| Month | -55.42% |
| Quarter | -72.68% |
| 6 Months | -43.40% |
| YTD | -50.33% |
| Year | -66.37% |
| 10 Years | -95.89% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $3.00 | 19,288 |
| 2026-10-26 | $2.73 | 14,700 |
| 2026-10-23 | $3.17 | 22,400 |
| 2026-10-22 | $3.46 | 11,700 |
| 2026-10-21 | $3.76 | 25,300 |
| 2026-10-20 | $3.80 | 22,700 |
| 2026-10-19 | $4.16 | 402,800 |
| 2026-10-16 | $3.98 | 28,200 |
| 2026-10-15 | $4.88 | 10,700 |
| 2026-10-14 | $5.14 | 13,700 |
| 2026-10-13 | $5.16 | 4,800 |
| 2026-10-12 | $5.28 | 22,300 |
| 2026-10-09 | $5.31 | 8,800 |
| 2026-10-08 | $6.12 | 21,600 |
| 2026-10-07 | $6.21 | 22,400 |
| 2026-10-06 | $6.38 | 15,400 |
| 2026-10-05 | $6.34 | 15,000 |
| 2026-10-02 | $6.73 | 27,100 |
| 2026-10-01 | $6.91 | 20,100 |
| 2026-09-30 | $6.23 | 14,900 |
| 2026-09-29 | $6.32 | 19,500 |
| 2026-09-28 | $6.73 | 43,200 |
About Advanced Biomed Inc.
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. It offers A+Pre, a device that prepares blood samples for testing; the AC-1000, a device that separates cancer cells from the rest of the blood; A+SCDrop, a device that isolates individual cells; and A+CellScan, a device that stains and automatically counts cancer cells. The company provides developed dye kits used to identify different types of cancer cells. It also offers FinTruth financial verification agent platform, an enterprise AI financial verification platform designed to compare and verify financial analysis and AI-generated financial content against underlying source documents and financial rules, and to produce source-traceable and auditable results. The company was founded in 2014 and is based in Tsuen Wan, Hong Kong.
đ° Latest News
No news articles available at the moment. Check back later for updates on ADVB.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | - | $0 | $0 | $0 |
| Operating Revenue | - | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | - | $2,541,572 | $3,071,223 | $2,374,371 |
| Other Income Expense | - | $-294,201 | $-682,956 | $-1,653,594 |
| Other Non Operating Income Expenses | - | $486 | $-21,111 | $-35,620 |
| Net Non Operating Interest Income Expense | - | $53,495 | $21,402 | $243 |
| Operating Expense | - | $2,541,572 | $3,071,223 | $2,374,371 |
| General And Administrative Expense | - | $1,261,777 | $1,322,811 | $624,774 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | - | $-2,782,278 | $-3,732,777 | $-4,027,722 |
| Net Interest Income | - | $53,495 | $21,402 | $243 |
| Interest Income | - | $53,495 | $21,402 | $243 |
| Normalized Income | - | $-2,487,591 | $-3,070,932 | $-2,409,748 |
| Net Income From Continuing And Discontinued Operation | - | $-2,782,278 | $-3,732,777 | $-4,027,722 |
| Net Income Common Stockholders | - | $-2,782,278 | $-3,732,777 | $-4,027,722 |
| Net Income | - | $-2,782,278 | $-3,732,777 | $-4,027,722 |
| Net Income Including Noncontrolling Interests | - | $-2,782,278 | $-3,732,777 | $-4,027,722 |
| Net Income Continuous Operations | - | $-2,782,278 | $-3,732,777 | $-4,027,722 |
| Pretax Income | - | $-2,782,278 | $-3,732,777 | $-4,027,722 |
| Special Income Charges | - | $0 | $-150,207 | $-1,617,974 |
| Interest Income Non Operating | - | $53,495 | $21,402 | $243 |
| Operating Income | - | $-2,541,572 | $-3,071,223 | $-2,374,371 |
| Depreciation Amortization Depletion Income Statement | - | $399,602 | $365,231 | $130,066 |
| Depreciation And Amortization In Income Statement | - | $399,602 | $365,231 | $130,066 |
| Per Share | ||||
| Diluted EPS | $-3.20 | $-2.57 | $-3.45 | $-0.64 |
| Basic EPS | $-3.20 | $-2.57 | $-3.45 | $-0.64 |
| Other | ||||
| Diluted Average Shares | $1,026,284 | $1,082,000 | $6,250,000 | $6,250,000 |
| Basic Average Shares | $1,026,284 | $1,082,000 | $6,250,000 | $6,250,000 |
| Tax Effect Of Unusual Items | - | $0 | $0 | $0 |
| Tax Rate For Calcs | - | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | - | $-1,847,283 | $-2,044,147 | $-626,331 |
| Total Unusual Items | - | $-294,687 | $-661,845 | $-1,617,974 |
| Total Unusual Items Excluding Goodwill | - | $-294,687 | $-661,845 | $-1,617,974 |
| Reconciled Depreciation | - | $399,602 | $365,231 | $126,632 |
| EBITDA (Bullshit earnings) | - | $-2,141,970 | $-2,705,992 | $-2,244,305 |
| EBIT | - | $-2,541,572 | $-3,071,223 | $-2,374,371 |
| Diluted NI Availto Com Stockholders | - | $-2,782,278 | $-3,732,777 | $-4,027,722 |
| Tax Provision | - | $0 | $0 | $0 |
| Gain On Sale Of Business | - | $0 | $-150,207 | - |
| Gain On Sale Of Security | - | $-294,687 | $-511,638 | - |
| Research And Development | - | $880,193 | $1,383,181 | $1,619,531 |
| Selling General And Administration | - | $1,261,777 | $1,322,811 | $624,774 |
| Other Gand A | - | $500,520 | $579,520 | $313,463 |
| Salaries And Wages | - | $761,257 | $743,291 | $311,311 |
| Impairment Of Capital Assets | - | - | $0 | $1,617,974 |
Fetched: 2026-10-24
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | - | $1,544,260 | $1,055,267 | $3,080,797 |
| Total Assets | - | $4,460,247 | $4,599,977 | $6,713,499 |
| Total Non Current Assets | - | $1,409,137 | $1,813,989 | $1,707,788 |
| Other Non Current Assets | - | $-1 | $56,127 | $71,021 |
| Non Current Deferred Assets | - | $638,871 | $553,471 | $0 |
| Goodwill And Other Intangible Assets | - | $118,998 | $250,321 | $410,799 |
| Other Intangible Assets | - | $118,998 | $250,321 | $410,799 |
| Current Assets | - | $3,051,110 | $2,785,988 | $5,005,711 |
| Prepaid Assets | - | $237,960 | $13,759 | $59,329 |
| Receivables | - | $205,177 | $149,950 | $162,518 |
| Receivables Adjustments Allowances | - | $0 | $0 | $0 |
| Other Receivables | - | $44,035 | $3,325 | $23,469 |
| Taxes Receivable | - | $161,142 | $146,625 | $139,049 |
| Cash Cash Equivalents And Short Term Investments | - | $2,607,973 | $2,622,279 | $4,783,864 |
| Cash And Cash Equivalents | - | $2,607,973 | $2,622,279 | $4,783,864 |
| Cash Financial | - | $2,607,973 | $2,622,279 | $4,783,864 |
| Debt | ||||
| Total Debt | - | $126,740 | $235,373 | $468,868 |
| Long Term Debt And Capital Lease Obligation | - | $64,529 | $18,806 | $232,191 |
| Current Debt And Capital Lease Obligation | - | $62,211 | $216,567 | $236,677 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | - | $2,796,989 | $3,294,389 | $3,221,903 |
| Total Non Current Liabilities Net Minority Interest | - | $64,529 | $18,806 | $232,191 |
| Current Liabilities | - | $2,732,460 | $3,275,583 | $2,989,712 |
| Payables And Accrued Expenses | - | $2,670,249 | $3,059,016 | $2,753,035 |
| Payables | - | $2,670,249 | $3,059,016 | $2,753,035 |
| Other Payable | - | $1,261,699 | $769,717 | $1,990,833 |
| Accounts Payable | - | $620,476 | $632,820 | $762,202 |
| Equity | ||||
| Common Stock Equity | - | $1,663,258 | $1,305,588 | $3,491,596 |
| Total Equity Gross Minority Interest | - | $1,663,258 | $1,305,588 | $3,491,596 |
| Stockholders Equity | - | $1,663,258 | $1,305,588 | $3,491,596 |
| Gains Losses Not Affecting Retained Earnings | - | $1,123,344 | $804,020 | $268,859 |
| Other Equity Adjustments | - | $1,123,344 | $804,020 | $268,859 |
| Retained Earnings | - | $-15,974,075 | $-13,191,797 | $-9,459,020 |
| Other | ||||
| Ordinary Shares Number | $1,082,000 | $1,082,000 | $1,082,000 | $1,082,000 |
| Share Issued | $1,082,000 | $1,082,000 | $1,082,000 | $1,082,000 |
| Tangible Book Value | - | $1,544,260 | $1,055,267 | $3,080,797 |
| Invested Capital | - | $1,663,258 | $1,305,588 | $3,491,596 |
| Working Capital | - | $318,650 | $-489,595 | $2,015,999 |
| Capital Lease Obligations | - | $126,740 | $235,373 | $468,868 |
| Total Capitalization | - | $1,663,258 | $1,305,588 | $3,491,596 |
| Additional Paid In Capital | - | $16,493,989 | $13,673,365 | $12,582,757 |
| Capital Stock | - | $20,000 | $20,000 | $99,000 |
| Common Stock | - | $20,000 | $20,000 | $99,000 |
| Long Term Capital Lease Obligation | - | $64,529 | $18,806 | $232,191 |
| Current Capital Lease Obligation | - | $62,211 | $216,567 | $236,677 |
| Dueto Related Parties Current | - | $788,074 | $1,656,479 | $0 |
| Net PPE | - | $651,269 | $954,070 | $1,225,968 |
| Accumulated Depreciation | - | $-1,230,457 | $-996,371 | $-805,624 |
| Gross PPE | - | $1,881,726 | $1,950,441 | $2,031,592 |
| Leases | - | $201,516 | $201,994 | $212,078 |
| Other Properties | - | $1,613,132 | $1,681,900 | $1,754,713 |
| Machinery Furniture Equipment | - | $67,078 | $66,547 | $64,801 |
| Properties | - | $0 | $0 | $0 |
Fetched: 2026-10-24
Cash Flow Statement (Annual)
| Metric | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-2,200,450 | $-3,176,148 | $-2,053,580 | $-499,417 |
| Operating Activities | ||||
| Operating Cash Flow | $-2,126,340 | $-2,963,625 | $-741,450 | $-473,975 |
| Cash Flow From Continuing Operating Activities | $-2,126,340 | $-2,963,625 | $-741,450 | $-473,975 |
| Operating Gains Losses | - | $150,207 | $37,634 | - |
| Investing Activities | ||||
| Capital Expenditure | $-74,110 | $-212,523 | $-1,312,130 | $-25,442 |
| Investing Cash Flow | $-74,110 | $-263,009 | $-1,083,684 | $-25,442 |
| Cash Flow From Continuing Investing Activities | $-74,110 | $-263,009 | $-1,083,684 | $-25,442 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $1,011,608 | $6,097,131 | $697,164 |
| Financing Cash Flow | $1,866,820 | $458,137 | $6,097,131 | $697,164 |
| Cash Flow From Continuing Financing Activities | $1,866,820 | $458,137 | $6,097,131 | $697,164 |
| Net Other Financing Charges | $294,900 | $-553,471 | - | - |
| Net Common Stock Issuance | $-85,400 | $1,011,608 | $6,097,131 | $697,164 |
| Common Stock Issuance | $0 | $1,011,608 | $6,097,131 | $697,164 |
| Other | ||||
| Issuance Of Debt | $1,657,320 | $0 | - | - |
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $2,607,973 | $2,622,279 | $4,783,864 | $65,922 |
| Beginning Cash Position | $2,622,279 | $4,783,864 | $65,922 | $65,705 |
| Effect Of Exchange Rate Changes | $319,324 | $606,912 | $445,945 | $-197,530 |
| Changes In Cash | $-333,630 | $-2,768,497 | $4,271,997 | $197,747 |
| Net Issuance Payments Of Debt | $1,657,320 | $0 | - | - |
| Net Long Term Debt Issuance | $1,657,320 | $0 | - | - |
| Long Term Debt Issuance | $1,657,320 | $0 | - | - |
| Net Business Purchase And Sale | $0 | $-50,486 | $199,527 | $0 |
| Sale Of Business | $0 | - | $199,527 | $0 |
| Net Intangibles Purchase And Sale | $0 | $-1,640 | $-422,536 | $0 |
| Purchase Of Intangibles | $0 | $-1,640 | $-422,536 | $0 |
| Net PPE Purchase And Sale | $-74,110 | $-210,883 | $-860,675 | $-25,442 |
| Purchase Of PPE | $-74,110 | $-210,883 | $-889,594 | $-25,442 |
| Interest Received Cfo | $53,495 | $21,402 | $243 | $28 |
| Change In Working Capital | $256,336 | $253,714 | $1,504,032 | $1,305,333 |
| Change In Other Current Liabilities | $0 | $-25,973 | $25,973 | $0 |
| Change In Other Current Assets | $56,127 | $14,894 | $0 | - |
| Change In Payables And Accrued Expense | $479,634 | $381,253 | $912,424 | $17,238 |
| Change In Payable | $479,634 | $381,253 | $912,424 | $17,238 |
| Change In Account Payable | $479,634 | $381,253 | $912,424 | $17,238 |
| Change In Prepaid Assets | $-279,425 | $-116,460 | $565,635 | $1,288,095 |
| Change In Receivables | $53,495 | $21,402 | $243 | $28 |
| Other Non Cash Items | $-53,495 | $-21,402 | $-243 | $-28 |
| Depreciation Amortization Depletion | $399,602 | $365,231 | $126,632 | $57,850 |
| Depreciation And Amortization | $399,602 | $365,231 | $126,632 | $57,850 |
| Amortization Cash Flow | $131,323 | $136,424 | $11,737 | $0 |
| Amortization Of Intangibles | $131,323 | $136,424 | $11,737 | $0 |
| Depreciation | $268,279 | $228,807 | $114,895 | $57,850 |
| Gain Loss On Sale Of Business | $0 | $150,207 | $0 | - |
| Net Income From Continuing Operations | $-2,782,278 | $-3,732,777 | $-4,027,722 | $-1,837,158 |
| Purchase Of Business | - | $-50,486 | $0 | - |
| Sale Of PPE | - | $0 | $28,919 | $0 |
| Asset Impairment Charge | - | $0 | $1,617,974 | $0 |
| Gain Loss On Sale Of PPE | - | $0 | $37,634 | $0 |
Fetched: 2026-10-24